Breaking Down C&S Paper Co.,Ltd Financial Health: Key Insights for Investors

C&S Paper Co., Ltd. (002511.SZ) presents a complex picture for investors: after a Q3 2025 revenue uptick to 2.15 billion CNY (+11.09% QoQ) the trailing twelve-month revenue still sits at 8.67 billion CNY (‑2.90% YoY) following a 2024 annual revenue decline to 8.15 billion CNY (‑16.84%) amid fierce competition and raw‑material volatility; yet profitability signals show improvement with H1 2025 net profit attributable to shareholders of 150 million CNY (+71.44% YoY) and a TTM ROE of 4.67%, while balance sheet strength is evidenced by a net cash position of 1.39 billion CNY (total debt 1.57 billion CNY, cash 2.96 billion CNY), a current ratio of 1.55, operating cash flow TTM of 952.56 million CNY and free cash flow of 636.89 million CNY-metrics that sit alongside valuation indicators like a trailing P/E of 39.26, EV/EBITDA of 12.13 and market cap of 10.26 billion CNY, plus an Altman Z‑Score of 3.44; explore the full breakdown inside to weigh the risks from competition, pulp price swings and capex demands against growth moves into personal care, channel expansion and higher‑margin products.

C&S Paper Co.,Ltd (002511.SZ) - Revenue Analysis

In Q3 2025, C&S Paper Co.,Ltd (002511.SZ) reported revenue of 2.15 billion CNY, representing an 11.09% increase versus Q2 2025. The trailing twelve months (TTM) revenue is 8.67 billion CNY, a 2.90% decrease year-over-year. For the full year 2024, the company recorded annual revenue of 8.15 billion CNY, down 16.84% from 2023.

• Q3 2025 revenue: 2.15 billion CNY (+11.09% QoQ)
• TTM revenue: 8.67 billion CNY (-2.90% YoY)
• 2024 annual revenue: 8.15 billion CNY (-16.84% vs 2023)

The 2024 revenue decline is primarily attributed to intensified market competition and volatility in raw material prices (pulp, chemicals). Management responses include business-structure adjustments and equity incentive programs aimed at stabilizing and expanding revenue streams while preserving market share in household paper products.

• Operational levers: portfolio rebalancing toward higher-margin household products, cost controls, targeted pricing strategies.
• Corporate actions: equity incentives to align management with revenue-growth targets and to accelerate product innovation/commercial execution.
• Competitive position: remains strong in household paper despite 2024 decline, benefiting from brand recognition and distribution network.

For strategic context and corporate guiding principles, see Mission Statement, Vision, & Core Values (2026) of C&S Paper Co.,Ltd.

C&S Paper Co.,Ltd (002511.SZ) - Profitability Metrics

• Net profit attributable to shareholders (H1 2025): 150 million CNY, up 71.44% YoY.
• Net profit margin (H1 2025): 3.46%, versus 2.02% in H1 2024.
• Gross profit margin (Q1 2025): 30.8%, marginally higher than 30.7% in Q4 2024.
• Trailing twelve months (TTM) return on equity (ROE): 4.67%.
• TTM earnings per share (EPS): 0.20 CNY; P/E ratio: 41.02.

• Cost control initiatives: procurement efficiencies, energy and logistics savings contributing to margin expansion.
• Product-mix optimization: higher-margin SKU weighting and selective pricing improved gross margin modestly in Q1 2025.
• Scale and utilization: production capacity utilization affects fixed-cost absorption and incremental margin on volume recovery.
• Market pricing and raw-material trends: pulp and packaging input costs remain a sensitivity to margins.

C&S Paper Co.,Ltd (002511.SZ) - Debt vs. Equity Structure

• Total debt: 1.57 billion CNY
• Cash & equivalents: 2.96 billion CNY
• Net cash: 1.39 billion CNY (cash minus debt)
• Debt-to-equity ratio: 0.29
• Equity-to-assets ratio: 0.52
• Interest coverage ratio: 8.14
• Current ratio: 1.55
• Share repurchases: 1.88% of shares bought back at a cost of 184 million CNY (as of Oct 31, 2025)

• Net cash position (1.39B CNY) reduces refinancing risk and supports strategic options.
• Debt-to-equity of 0.29 and equity-to-assets of 0.52 indicate a balanced, low-leverage capital structure.
• Interest coverage of 8.14 provides a comfortable cushion against earnings variability.
• Share repurchases (1.88% / 184M CNY) signal management focus on returning capital and boosting shareholder value.

C&S Paper Co.,Ltd (002511.SZ) - Liquidity and Solvency

C&S Paper's short-term liquidity and overall solvency metrics point to a financially stable position with room to support operations and planned expansion.

• Current ratio: 1.55 - sufficient short-term assets to cover current liabilities.
• Quick ratio: 1.09 - adequate immediate liquidity excluding inventories.
• Net cash position: ¥1.39 billion CNY - buffer against cash-flow variability and downturns.
• Operating cash flow (TTM): ¥952.56 million CNY.
• Free cash flow (TTM): ¥636.89 million CNY.
• Capital expenditures (last 12 months): ¥315.67 million CNY - reflects capacity expansion investments.
• Altman Z-Score: 3.44 - indicates low bankruptcy risk under standard interpretation.

Key figures in one view:

Implications for stakeholders:

• Liquidity cushions (current and quick ratios) reduce short-term refinancing risk and support supplier and payroll obligations.
• Positive operating and free cash flow imply the business generates cash from operations after investment needs, enabling deleveraging or further capex.
• Net cash of ¥1.39B combined with a Z-Score of 3.44 suggests resilience to cyclical stress and lower bankruptcy probability.
• Capital expenditures of ¥315.67M show active investment in capacity; investors should monitor return on invested capital to assess payoff.

For broader corporate context and how these financial decisions tie into strategy and ownership, see: C&S Paper Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

C&S Paper Co.,Ltd (002511.SZ) - Valuation Analysis

The valuation profile of C&S Paper Co.,Ltd (002511.SZ) shows a company trading at moderate multiples relative to earnings, sales, book value and cash flow, with lower volatility versus the market. Below are the key valuation metrics and brief context for investors.

• Trailing P/E: 39.26 - higher multiple on historical earnings, implying expectations of continued profitability growth or limited near-term earnings base.
• Forward P/E: 36.17 - slightly lower than trailing P/E, suggesting analysts expect earnings to improve.
• P/S ratio: 1.18 - reasonable relative to revenue generation; indicates market values roughly 1.18 CNY of equity per 1 CNY of sales.
• P/B ratio: 1.86 - market values the company at nearly twice its book equity, pointing to modest premium for intangible/assets or growth potential.
• EV/EBITDA: 12.13 - typical mid-range valuation versus peers; signals how the market prices operating earnings irrespective of capital structure.
• EV/FCF: 13.95 - valuation relative to free cash flow indicates a moderate multiple on cash-generative capacity.
• Market Capitalization: 10.26 billion CNY - equity value.
• Enterprise Value: 8.89 billion CNY - reflects total firm value after accounting for cash/debt adjustments.
• Beta: 0.70 - lower historical volatility than the broader market, useful for portfolio risk considerations.

For additional company context including strategic direction and core values, see: Mission Statement, Vision, & Core Values (2026) of C&S Paper Co.,Ltd.

C&S Paper Co.,Ltd (002511.SZ) - Risk Factors

• Intensified competition in household paper products: domestic and regional rivals (local brands and private-label retail lines) have driven ASP compression-gross margins narrowed by several hundred basis points in past weak pricing periods, pressuring operating profit.
• Fluctuations in raw material prices, particularly pulp: pulp accounts for a material share of production cost (industry estimates and company disclosures imply raw materials can represent ~30-40%+ of COGS). A USD 100/ton swing in pulp can change margins meaningfully; historically pulp volatility has translated into quarterly gross-margin swings of 1-3 percentage points.
• Significant capital expenditures: the company's multi-year capex (RMB ~1.5-2.5 billion per year range recently) to expand capacity and upgrade mills limits free cash flow and increases refinancing needs, especially if operating cash flow weakens.
• Dependence on the domestic market: a large share of sales is domestic China exposure-regional economic slowdowns, weaker consumption, or channel shifts to lower-priced SKUs could reduce volume and mix-driven margins.
• Regulatory changes and environmental policy risk: tightening emissions/wastewater rules could require additional investment or lead to temporary plant curtailments. Historical industry compliance capex can be several hundred million RMB for retrofit cycles.
• Debt-level sensitivity: while net gearing (~25%) is moderate, leverage could become a concern if EBITDA contracts-interest coverage could deteriorate and restrict dividend policy or new investment capacity.

• Raw material shock: a sustained +20% pulp price rise could compress gross margin by ~200-400 bps and reduce net income by a mid-to-high single-digit percentage of current earnings.
• Demand shock: a 10% drop in volumes (from regional slowdown or intensified price competition) could reduce revenue by ~RMB 2.9 billion and materially stress cash generation given ongoing capex.
• Regulatory capex event: an unplanned environmental retrofit costing RMB 500-800 million would raise leverage and temporarily depress free cash flow and ROIC.

• Hedging and procurement: multi-sourcing and forward purchasing to reduce pulp exposure (degree of hedging varies by period).
• Efficiency programs: ongoing productivity and yield improvements to offset input-cost inflation.
• Prudent financing: maintaining a mix of short- and long-term debt to smooth maturities and preserve liquidity lines.

C&S Paper Co.,Ltd (002511.SZ) - Growth Opportunities

• Expand into personal care categories (baby care, adult incontinence, feminine care) to capture higher ASPs and cross-sell into existing retail footprints.
• Enhance offline distribution network and improve channel efficiency by consolidating distributors, strengthening regional logistics and providing retailer-level promotions/support.
• Accelerate presence on new retail and e-commerce platforms (vertical marketplaces, social commerce, livestreaming) to reach younger demographics and increase direct-to-consumer sales.
• Develop high-end, high-margin SKUs (premium tissue, functional wipes, upgraded packaging) to lift blended gross margins and profitability.
• Explore second/third growth curves such as health-related disposables (medical-grade wipes, PPE consumables) and home cleaning chemicals/agents to diversify revenue streams.
• Invest in capacity expansion and technological upgrades (automated converting lines, energy-efficient papermaking equipment, R&D for product formulations) to support long-term volume growth and cost control.

• Personal care expansion: targeted SKUs with higher ASPs-management guidance targets personal-care revenue contribution rising from low-single digits to ~10-15% of total over 3 years.
• Offline channel efficiency: expected gross-to-net uplift of 1-2 percentage points via optimized distribution and SKU rationalization.
• E‑commerce acceleration: aim to increase online share to 25-30% within 3 years, improving gross margin due to direct channel economics.
• High‑end product push: premiumization expected to raise blended margin by ~1-2 ppt annually as portfolio mix shifts.
• New growth curves (health/home cleaning): initial projects and pilot SKUs underway; target is to reach mid-single-digit revenue shares within 3-5 years if commercialization succeeds.
• CapEx & tech upgrades: RMB ~1.0-1.5bn annual investment window to support automated converting, capacity scale and energy efficiency-lowering per-unit cash cost over time.

• Monthly/quarterly e‑commerce GMV and DTC repeat-purchase rates.
• SKU-level gross margins for new personal-care and premium tissue lines.
• Distributor inventory days and sell-through in key provinces-indicator of offline channel momentum.
• Utilization rate of new converting lines and time-to-market for health/home cleaning launches.
• Quarterly capex deployment and expected commissioning dates for capacity additions.